Shares of this smallcap company jumped around 5 percent in Monday’s trading session after entering into a Long-term supply Agreement with a multinational company.
With a market capitalization of Rs. 1,350 crores, the shares of Excel Industries Ltd started Monday’s trading session on a higher note at Rs. 1,045.30 compared to its previous close of Rs. 1,029.85. During the trading session, the shares hit a high of Rs. 1,087, gaining around 5 percent and are currently trading at Rs. 1,069 apiece.
Such a bullish movement in the share price was observed after the company in an exchange filing announced that they had signed a long-term agreement with a leading Multinational company for the supply of a niche chemical.
This contract, spanning 5 years, is projected to generate an estimated revenue of Rs. 50 to 70 crores for the company over the duration of the contract. This agreement will be the starting point for Excel’s entry into contract manufacturing.
Coming onto the company’s financial statements, the revenue zoomed by 30 percent from Rs. 180.28 crores during the December quarter to Rs. 233.54 crores in the March quarter. In addition, the net profits magnified by 149 percent from Rs. 2.68 crores to Rs. 6.67 crores during the same period.
The company has 3 state-of-the-art large-scale manufacturing sites in Roha, Lote and Vishakhapatnam. It specializes in Agro Chemical Intermediates, Specialty Chemicals, Polymer Inputs and Pharmaceutical API and Intermediates.
Furthermore, the company has executed Rs 316 crores of Capex throughout the four-year term (2019–23), which included the acquisition of the Visakhapatnam site and the company is in the process of setting up a state-of-the-art R&D facility in Mumbai.
In terms of key financial metrics, the company reported a Return on Equity (RoE) of 1.19 percent and a return on capital employed (RoCE) of 1.54 percent for the period spanning FY23-24.
Headquartered in Maharashtra, Excel Industries is a diversified chemical conglomerate with a strong focus on industrial and speciality chemicals, agrochemicals, waste management solutions, and pharmaceutical intermediates.
Written By Vaibhav Patil
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
